A Study of LY900010 in Erectile Dysfunction

Summary

The primary purpose of the study is to compare the efficacy of LY2452473 + tadalafil to tadalafil alone in improving the erectile function (EF) of men with erectile dysfunction (ED) who incompletely respond to tadalafil alone.

Timeline

Start

2010-10

Primary completion

2011-11

Completion

2011-11

Outcome

Missed primary endpoint

registry analysis (superiority or other test); 1 mg LY2452473 and 5 mg Tadalafil vs 5 mg Tadalafil; p = 0.5; NCT01160289 ↗

registry analysis (superiority or other test); 5 mg LY2452473 and 5 mg Tadalafil vs 5 mg Tadalafil; p = 0.498; NCT01160289 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LY2452473	Small molecule	1 mg	Oral
Subject	LY2452473	Small molecule	5 mg	Oral
Subject	Tadalafil	Small molecule	5 mg	Oral
Subject	Tadalafil	Small molecule	10 mg	Oral

Indications